10-Q Filing

UNI-PIXEL CIK: 1171012 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001185185-13-002329`
Period End Date	20130930
Filing Date	20131107
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	unxl-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 49 Cash Flow Statement 51 Stockholders Equity 22

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$3.76M	USD	Point-in-time
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.53M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Common stock, shares authorized (in Shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in Shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued (in Shares)	`CommonStockSharesIssued`	9.85M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$160.32K	USD	Point-in-time
Common stock, shares issued (in Shares)	`CommonStockSharesIssued`	12.19M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$46.63M	USD	Point-in-time
Common stock, shares outstanding (in Shares)	`CommonStockSharesOutstanding`	9.85M	shares	Point-in-time
Common stock, shares outstanding (in Shares)	`CommonStockSharesOutstanding`	12.19M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $3,760,789 and $2,531,917, at September 30, 2013 and December 31, 2012, respectively	`PropertyPlantAndEquipmentNet`	$1.54M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $3,760,789 and $2,531,917, at September 30, 2013 and December 31, 2012, respectively	`PropertyPlantAndEquipmentNet`	$13.57M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Total assets	`Assets`	$14.71M	USD	Point-in-time
Total assets	`Assets`	$60.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.23M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$348.68K	USD	Point-in-time
Bonus accrual	`OtherAccruedLiabilitiesCurrent`	$273.68K	USD	Point-in-time
Bonus accrual	`OtherAccruedLiabilitiesCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$348.68K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$348.68K	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,189,570 shares issued and outstanding at September 30, 2013 and 9,854,268 shares issued and outstanding at December 31, 2012	`CommonStockValue`	$12.19K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,189,570 shares issued and outstanding at September 30, 2013 and 9,854,268 shares issued and outstanding at December 31, 2012	`CommonStockValue`	$9.85K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$85.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$134.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.36M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$14.37M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$8.30M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$53.72M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$60.22M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$14.71M	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$74.12K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	-	USD	1 Quarter
Revenue	`SalesRevenueNet`	$5.07M	USD	3 Qtrs
Revenue	`SalesRevenueNet`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$25.48K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$3.42K	USD	3 Qtrs
Gross margin	`GrossProfit`	-	USD	1 Quarter
Gross margin	`GrossProfit`	-	USD	1 Quarter
Gross margin	`GrossProfit`	$5.07M	USD	3 Qtrs
Gross margin	`GrossProfit`	$48.65K	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.48M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$6.83M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.65M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$829.63K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.83M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.53M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.29M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.05M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.06M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.13M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.31M	USD	1 Quarter
Interest income, net	`InterestExpense`	$-5.27K	USD	3 Qtrs
Interest income, net	`InterestExpense`	$-2.45K	USD	1 Quarter
Interest income, net	`InterestExpense`	$-6.83K	USD	1 Quarter
Interest income, net	`InterestExpense`	$-13.30K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.24	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.80	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.80	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.44	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.80	USD	3 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.44	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.24	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.80	USD	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.09M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.27M	shares	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.63M	shares	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	8.60M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.60M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.27M	shares	3 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.09M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.63M	shares	3 Qtrs

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$378.94K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.23M	USD	3 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.31M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.85M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$2.41M	USD	3 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.55K	USD	3 Qtrs
(Increase) decrease in prepaid assets	`IncreaseDecreaseInPrepaidExpense`	$-160.32K	USD	3 Qtrs
(Increase) decrease in prepaid assets	`IncreaseDecreaseInPrepaidExpense`	$211.07K	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$16.12K	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$879.39K	USD	3 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	-	USD	3 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	$273.68K	USD	3 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	3 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$5.00M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.22M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.09M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.26M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.57K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.57K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.26M	USD	3 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	$175.98K	USD	3 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$3.28M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$12.27M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$41.22M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.27M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.68M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$8.15M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$33.63M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$15.37M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$15.37M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the nine months ended September 30, 2013. Issuance of 2,722 shares of common stock in exchange for the cashless exercise of warrants to purchase 33,542 shares of common stock for the nine months ended September 30, 2012.	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$16.34K	USD	3 Qtrs
Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the nine months ended September 30, 2013. Issuance of 2,722 shares of common stock in exchange for the cashless exercise of warrants to purchase 33,542 shares of common stock for the nine months ended September 30, 2012.	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$2.15M	USD	3 Qtrs

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$53.72M	USD	Point-in-time
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.48M	USD	Annual
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.41M	USD	3 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$175.98K	USD	3 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$87.51K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.28M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$12.50K	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$228.16K	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$1.31M	USD	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$12.27M	USD	Annual
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$41.22M	USD	3 Qtrs
Issuance of common stock, net of issuance costs (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.37M	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	3 Qtrs
Balance	`StockholdersEquity`	$8.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$53.72M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.